$3.99 -0.06 (%) Arena Pharmaceuticals Inc - NASDAQ

Jul. 27, 2015 | 04:00 PM

Partner Headlines

  1. Wednesday's Mid-Day Movers: Does The U.S. Benefit From Iran Deal?; Celgene-Receptors And More

    Benzinga | Jul. 15, 2015 | 12:39PM EST
  2. Wednesday's Mid-Day Movers: Does The U.S. Benefit From Iran Deal?; Celgene-Receptos And More

    Benzinga | Jul. 15, 2015 | 12:39PM EST
  3. Celgene Hits High As Street Applauds Receptos Buyout

    IBD | Jul. 15, 2015 | 11:12AM EST
  4. Mid-Morning Market Update: Markets Mostly Higher; Bank Of America Tops Q2 Views

    Benzinga | Jul. 15, 2015 | 10:56AM EST
  5. Sportsman's Warehouse, Bob Evans, Peabody Energy Lead Tuesday's After-Hours Movers

    Benzinga | Jun. 16, 2015 | 17:52PM EST
  6. 5 New Biotech Developments Worth Watching

    Benzinga | May. 13, 2015 | 11:35AM EST
  7. Morning Market Gainers

    Benzinga | Apr. 29, 2015 | 09:46AM EST
  8. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 29, 2015 | 08:15AM EST
  9. Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research

    Benzinga | Apr. 20, 2015 | 08:38AM EST
  10. Orexigen Soars On Obesity Drug's Surprise Health Boon

    IBD | Mar. 3, 2015 | 13:54PM EST
  11. Morning Market Losers

    Benzinga | Mar. 3, 2015 | 10:02AM EST
  12. Benzinga's Top #PreMarket Losers

    Benzinga | Mar. 3, 2015 | 08:23AM EST
  13. 10 Stocks You Should Be Watching Today

    Benzinga | Mar. 3, 2015 | 04:32AM EST
  14. Arena Pharmaceuticals Misses Q4 Expectations

    Benzinga | Mar. 2, 2015 | 18:45PM EST
  15. Earnings Scheduled For March 2, 2015

    Benzinga | Mar. 2, 2015 | 04:44AM EST
  16. CNBC's Stock Pops & Drops From January 21

    Benzinga | Jan. 21, 2015 | 21:14PM EST
  17. Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shares Spike Higher

    Benzinga | Jan. 21, 2015 | 15:10PM EST
  18. 4 More Biotech Secondaries Traders Are Watching

    Benzinga | Jan. 21, 2015 | 13:38PM EST
  19. Mid-Day Market Update: U.S. Stocks Surge; Netflix Shares Jump On Upbeat Earnings

    Benzinga | Jan. 21, 2015 | 12:53PM EST
  20. Mid-Morning Market Update: Markets Mixed; UnitedHealth Profit Tops Expectations

    Benzinga | Jan. 21, 2015 | 10:42AM EST
  21. Morning Market Losers

    Benzinga | Jan. 21, 2015 | 09:55AM EST
  22. Wednesday Morning Movers: Netflix Flying High

    Benzinga | Jan. 21, 2015 | 08:55AM EST
  23. Arena Pharmaceuticals Announces Agreement to Sell Common Stock

    Benzinga | Jan. 21, 2015 | 08:45AM EST
  24. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 21, 2015 | 08:23AM EST
  25. Tuesday's After-Hours Movers: Netflix Leads The Pack

    Benzinga | Jan. 20, 2015 | 17:25PM EST
  26. 5 Obesity Stocks Investors Are Watching

    Benzinga | Jan. 14, 2015 | 13:55PM EST
  27. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  28. Mid-Afternoon Market Update: Dow Jumps Over 200 Points After Fed Minutes; RPM Shares Drop On Downbeat Results

    Benzinga | Jan. 7, 2015 | 15:17PM EST
  29. Mid-Day Market Update: J C Penney Jumps On Strong Holiday Sales; Micron Shares Decline

    Benzinga | Jan. 7, 2015 | 13:11PM EST
  30. Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops Estimates

    Benzinga | Jan. 7, 2015 | 10:59AM EST
  31. Morning Market Gainers

    Benzinga | Jan. 7, 2015 | 09:38AM EST
  32. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 7, 2015 | 08:10AM EST
  33. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  34. Orexigen Therapeutics Gains On Diet Pill Nod From European Committee

    Benzinga | Dec. 19, 2014 | 14:09PM EST
  35. Pharmaceutical Stocks In Play Following Merck/Cubist Deal

    Benzinga | Dec. 8, 2014 | 09:09AM EST
  36. What's Driving Orexigen Therapeutics Higher?

    Benzinga | Nov. 13, 2014 | 12:10PM EST
  37. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 3, 2014 | 08:09AM EST
  38. Arena Pharma Reports Q3 EPS Loss $0.05, Revenues Of $8.16M Vs. Est. Of $11.0M

    Benzinga | Nov. 3, 2014 | 06:48AM EST
  39. Earnings Scheduled For November 3, 2014

    Benzinga | Nov. 3, 2014 | 05:18AM EST
  40. 3 Pharma Companies Fighting Obesity

    Benzinga | Oct. 30, 2014 | 14:00PM EST
  41. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 29, 2014 | 08:12AM EST
  42. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  43. Eisai And Arena Pharmaceuticals Announce Publication Of Pooled Phase 3 Clinical Trial Analysis Of BELVIQ (lorcaserin HCl) CIV In Postgraduate Medicine

    Benzinga | Oct. 10, 2014 | 11:37AM EST
  44. Earnings Scheduled For August 1, 2014

    Benzinga | Aug. 1, 2014 | 05:23AM EST
  45. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 11, 2014 | 08:19AM EST
  46. Markets Marginally Lower Ahead Of Earnings Season

    Benzinga | Jul. 7, 2014 | 16:37PM EST
  47. Arena Pharmaceutical Shares Dive On News CEO Sold 40% Of His Shares

    Benzinga | Jul. 7, 2014 | 12:45PM EST
  48. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 7, 2014 | 08:13AM EST
  49. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga | Jun. 17, 2014 | 10:48AM EST
  50. FDA delays Orexigen drug

    IBD | Jun. 11, 2014 | 18:57PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!